Skip to main navigation
Skip to search
Skip to main content
Status Finished Effective start/end date 21/03/22 → 30/06/23
Inflammation
Pharmacology, Toxicology and Pharmaceutical Science
100%
Idronoxil
Pharmacology, Toxicology and Pharmaceutical Science
100%
Phosphotransferase
Pharmacology, Toxicology and Pharmaceutical Science
100%
Diseases
Pharmacology, Toxicology and Pharmaceutical Science
100%
Malignant Neoplasm
Pharmacology, Toxicology and Pharmaceutical Science
100%
Immunotherapy
Pharmacology, Toxicology and Pharmaceutical Science
100%
Chemotherapy Regimens
Pharmacology, Toxicology and Pharmaceutical Science
100%
Mitogen Activated Protein Kinase 3
Pharmacology, Toxicology and Pharmaceutical Science
100%